Publications by authors named "Donato Natale"

Claim this Profile
P
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab-paclitaxel plus gemcitabine as second or later-line treatment.
Guido Giordano, Michele Milella, Matteo Landriscina, Francesca Bergamo, Giuseppe Tirino, Donato Natale

Cancer Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors for 6 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer.
Vincenzo Formica, Maria Teresa Ionta, Bruno Massidda, Giacomo Vessia, Luigi Maiorino, Donato Natale

Oncotarget· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.
Sandro Pignata, Giovanni Scambia, Alessandra Bologna, Simona Signoriello, Ignace B Vergote, Donato Natale

J Clin Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC.
Francesco Perrone, Gustavo Baldassarre, Stefano Indraccolo, Simona Signoriello, Gennaro Chiappetta, Donato Natale

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial.
Sandro Pignata, Giovanni Scambia, Gabriella Ferrandina, Antonella Savarese, Roberto Sorio, Donato Natale

J Clin Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
Pasquale Comella, Bruno Massidda, Donato Natale, Carlo Putzu, Claudia Sandomenico

Clin Colorectal Cancer· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
Pasquale Comella, Bruno Massidda, Gianfranco Filippelli, Antonio Farris, Donato Natale

J Cancer Res Clin Oncol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bisphosphonate-associated osteonecrosis of the jaw: a review of 35 cases and an evaluation of its frequency in multiple myeloma patients.
Samantha Pozzi, Raffaella Marcheselli, Stefano Sacchi, Luca Baldini, Francesco Angrilli, Donato Natale

Leuk Lymphoma· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of a 3-weekly schedule of carboplatin plus pegylated liposomal doxorubicin as first line chemotherapy in patients with ovarian cancer: preliminary results of the MITO-2 randomized trial.
Sandro Pignata, Giovanni Scambia, Antonella Savarese, Enrico Breda, Paolo Scollo, Donato Natale

BMC Cancer· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of irinotecan plus high-dose leucovorin and intravenous bolus 5-fluorouracil for metastatic colorectal cancer: pooled analysis of two consecutive southern Italy cooperative oncology group trials.
Pasquale Comella, Bruno Massidda, Gianfranco Filippelli, Donato Natale, Antonio Farris

Clin Colorectal Cancer· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine plus oxaliplatin for the first-line treatment of elderly patients with metastatic colorectal carcinoma: final results of the Southern Italy Cooperative Oncology Group Trial 0108.
Pasquale Comella, Donato Natale, Antonio Farris, Antonio Gambardella, Luigi Maiorino

Cancer· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.
Pasquale Comella, Antonio Gambardella, Antonio Farris, Luigi Maiorino, Donato Natale

Crit Rev Oncol Hematol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Chemoradiotherapy. Therapeutic indications: the doctor's point of view].
Donato Natale, Dante Orlando

Suppl Tumori· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis